| Literature DB >> 34134020 |
Janna A Hol1, Rosalyn Jewell2, Tanzina Chowdhury3, Catriona Duncan4, Kayo Nakata5, Takaharu Oue6, Marion Gauthier-Villars7, Annemieke S Littooij8, Yasuhiko Kaneko9, Norbert Graf10, Franck Bourdeaut11, Marry M van den Heuvel-Eibrink1, Kathy Pritchard-Jones3, Eamonn R Maher12, Christian P Kratz13, Marjolijn C J Jongmans14.
Abstract
Since previous consensus-based Wilms tumour (WT) surveillance guidelines were published, novel genes and syndromes associated with WT risk have been identified, and diagnostic molecular tests for previously known syndromes have improved. In view of this, the International Society of Pediatric Oncology (SIOP)-Europe Host Genome Working Group and SIOP Renal Tumour Study Group hereby present updated WT surveillance guidelines after an extensive literature review and international consensus meetings. These guidelines are for use by clinical geneticists, pediatricians, pediatric oncologists and radiologists involved in the care of children at risk of WT. Additionally, we emphasise the need to register all patients with a cancer predisposition syndrome in national or international databases, to enable the development of better tumour risk estimates and tumour surveillance programs in the future. CrownEntities:
Keywords: Cancer predisposition syndrome; Nephroblastoma; Overgrowth syndrome; Surveillance; WT1; Wilms tumour
Mesh:
Year: 2021 PMID: 34134020 DOI: 10.1016/j.ejca.2021.05.014
Source DB: PubMed Journal: Eur J Cancer ISSN: 0959-8049 Impact factor: 9.162